Cargando…
Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up
BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutivel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518448/ https://www.ncbi.nlm.nih.gov/pubmed/31092225 http://dx.doi.org/10.1186/s12888-019-2098-3 |
_version_ | 1783418451126124544 |
---|---|
author | Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter Perrin, Sean Nyhlén, Anna |
author_facet | Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter Perrin, Sean Nyhlén, Anna |
author_sort | Fridell, Mats |
collection | PubMed |
description | BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970–1995 was followed-up for 42 years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis. RESULTS: Forty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04–6.11) and 4.98 (CI 95%; 4.08–5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women. Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality. Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse. CONCLUSION: Psychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders. |
format | Online Article Text |
id | pubmed-6518448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65184482019-05-21 Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter Perrin, Sean Nyhlén, Anna BMC Psychiatry Research Article BACKGROUND: We need to better understand how the use of different substances and psychiatric comorbidity influence premature death generally and cause-specific death by overdose, intoxication and somatic disorders in people with substance use disorders. METHOD: A cohort of 1405 patients consecutively admitted to a Swedish detoxification unit for substance use disorders in 1970–1995 was followed-up for 42 years. Substances were identified by toxicological analyses. Mortality figures were obtained from a national registry. Causes of death were diagnosed by forensic autopsy in 594 patients deceased by 2012. Predictions were calculated by competing risks analysis. RESULTS: Forty-two per cent of the cohort died during follow-up; more men than women (46.3% vs 30.4%). The standardised mortality ratio (SMR) was calculated as the ratio of observed deaths in males and females in specific age groups in the cohort versus expected deaths in corresponding groups in the general population. SMR was 5.68 for men (CI 95%; 5.04–6.11) and 4.98 (CI 95%; 4.08–5.88) for women. The crude mortality rate (number of deaths divided by number of person observation years) was 2.28% for men and 1.87% for women. Opiates predicted increased risk of premature death while amphetamine and cannabis predicted lower risk. Comorbid psychiatric disorders were identified in 378 cases and personality disorders in 763 cases. Primary psychoses or mood/depression and anxiety disorders predicted a higher risk of premature mortality. Death by overdose was predicted by male gender, younger age at admission to substance treatment, opiate use, and comorbid depression and anxiety syndromes. Cannabis and amphetamine use predicted a lower risk of overdose. Death by intoxication was predicted by male gender, use of sedatives/hypnotics or alcohol/mixed substances, primary psychoses and depression/anxiety syndromes. Premature death by somatic disorder was predicted by male gender and alcohol/mixed abuse. CONCLUSION: Psychiatric comorbid disorders were important risk factors for premature drug-related death. Early identification of these factors may be life-saving in the treatment of patients with substance use disorders. BioMed Central 2019-05-15 /pmc/articles/PMC6518448/ /pubmed/31092225 http://dx.doi.org/10.1186/s12888-019-2098-3 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Fridell, Mats Bäckström, Martin Hesse, Morten Krantz, Peter Perrin, Sean Nyhlén, Anna Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title | Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title_full | Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title_fullStr | Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title_full_unstemmed | Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title_short | Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
title_sort | prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518448/ https://www.ncbi.nlm.nih.gov/pubmed/31092225 http://dx.doi.org/10.1186/s12888-019-2098-3 |
work_keys_str_mv | AT fridellmats predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup AT backstrommartin predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup AT hessemorten predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup AT krantzpeter predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup AT perrinsean predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup AT nyhlenanna predictionofpsychiatriccomorbidityonprematuredeathinacohortofpatientswithsubstanceusedisordersa42yearfollowup |